Document is current
Any future updates will be listed below
-
Authors
Seenappa, Lochana M.
Jakubowski, Aniela
Steinbuck, Martin P. http://orcid.org/0000-0001-5599-8953
Palmer, Erica
Haqq, Christopher M. http://orcid.org/0000-0001-8600-9548
Carter, Crystal http://orcid.org/0000-0001-8929-3839
Fontenot, Jane
Villinger, Francois http://orcid.org/0000-0002-7790-2008
McNeil, Lisa K.
DeMuth, Peter C. http://orcid.org/0000-0002-7044-7559
-
Funding
Funding for this research was provided by:
Elicio Therapeutics
- License Information
-
More Information
Article History
Received: 19 May 2022
Accepted: 12 October 2022
First Online: 28 October 2022
Competing interests
: L.M.S., A.J., M.P.S., E.P., C.M.H., L.K.M, and P.C.D. are employees of Elicio Therapeutics and, as such, receive salary and benefits, including ownership of stock and stock options from the company. P.C.D., M.P.S., L.M.S., and C.M.H. have an Amphiphile SARS-CoV-2 vaccine patent pending to Elicio. The other authors declare no competing interests.
